My Genome. My Health. MyOme.
MyOme is a clinical whole genome analysis platform helping patients and providers understand genetic risk for inherited diseases. Using whole genome sequencing and proprietary bioinformatics, MyOme produces actionable reports covering rare disease, medication response, and polygenic risk. Founded in 2017 and based in San Francisco.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.
Create Free Account